IP Verse

Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta Adrenergic For Administration By Inhalation - EP3019153

PATENT ANALYSIS

Patent Details

Grant Date
Sep 5, 2018
Company
CHIESI FARMACEUTICI S.P.A.
Oppositions

TEVA UK LIMITED

More patents of Chiesi Farmaceutici S.P.A.

EP2104490

EP3500241

EP2890437

Want to monitor this patent?

Feel free to send us a message here and we will get back to you